News
The Greek Football Federation has signed a landmark five-year kit deal with Adidas, replacing Nike starting in 2026. The ...
PLC ("TC BioPharm" or the "Company") (OTC: TCBPY) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...
In his restraining order filing against Glenna Bevin, Jonah Bevin is seeking more details about the woman he was told is his ...
The court announcing it will follow the EPO on inventive step, a case with a Chinese element, and three big settlements were ...
Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical ...
EPO: Biotech innovation strong, while pharma trails behind ...
Algernon Pharmaceuticals (AGNPF) announces that it has received a notice of allowance from the European Patent Office, EPO, for patent ...
Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is ...
Fabio Wardley and Jarrell Miller went face to face at a press conference for their June 7 showdown but it soon turned nasty ...
EPO data shows strong European innovation as markets tumble ...
Converting from the long-acting ESA methoxy polyethylene glycol-epoetin-ß (MPG-EPO) to thrice weekly vadadustat is feasible for the hemodialysis population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results